Payment overview · 2025
General Payments
$24.99
1 reported records · 1 companies
Healthcare provider profile · identity verified
Eric A. Enriquez, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · LAWNDALE, CA · NPI 1225038573
Verified facts
What the public records show
CMS Open Payments records show Eric A. Enriquez, M.D. received $24.99 in general payments during 2025 across 1 reported records.
GE HEALTHCARE accounted for 100.0% of that reported general-payment amount.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| GE HEALTHCARE | Unresolved — no canonical attribution shown | $24.99 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $24.99 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
Payment records were found, but the reported records did not identify a specific associated product for this analysis.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1582 | 493 |
| Metformin Hcl | Metformin Hcl | 969 | 304 |
| Amlodipine Besylate | Amlodipine Besylate | 763 | 224 |
| Losartan Potassium | Losartan Potassium | 746 | 213 |
| Lisinopril | Lisinopril | 555 | 161 |
| Levothyroxine Sodium | Levothyroxine Sodium | 481 | 131 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 429 | 136 |
| Omeprazole | Omeprazole | 382 | 140 |
| Azithromycin | Azithromycin | 340 | 252 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 305 | 95 |
| Ibuprofen | Ibuprofen | 293 | 80 |
| Furosemide | Furosemide | 286 | 111 |
| Alendronate Sodium | Alendronate Sodium | 282 | 87 |
| Pantoprazole Sodium | Pantoprazole Sodium | 266 | 74 |
| Tamsulosin Hcl | Tamsulosin Hcl | 266 | 86 |
| Simvastatin | Simvastatin | 233 | 63 |
| Benazepril Hcl | Benazepril Hcl | 223 | 62 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 217 | 45 |
| Atenolol | Atenolol | 215 | 62 |
| Metoprolol Succinate | Metoprolol Succinate | 213 | 62 |
| Gabapentin | Gabapentin | 209 | 87 |
| Alprazolam | Alprazolam | 195 | 47 |
| Metoprolol Tartrate | Metoprolol Tartrate | 191 | 55 |
| Hydrochlorothiazide | Hydrochlorothiazide | 188 | 52 |
| Famotidine | Famotidine | 173 | 57 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 169 | 61 |
| Allopurinol | Allopurinol | 168 | 55 |
| Betamethasone Diprop Augmented | Betamethasone/Propylene Glyc | 168 | 83 |
| Prednisone | Prednisone | 159 | 110 |
| Lorazepam | Lorazepam | 158 | 38 |
| Hydralazine Hcl | Hydralazine Hcl | 157 | 56 |
| Carvedilol | Carvedilol | 151 | 45 |
| Clopidogrel | Clopidogrel Bisulfate | 148 | 45 |
| Trazodone Hcl | Trazodone Hcl | 143 | 49 |
| Tramadol Hcl | Tramadol Hcl | 139 | 36 |
| Zolpidem Tartrate | Zolpidem Tartrate | 138 | 20 |
| Ozempic | Semaglutide | 137 | 24 |
| Temazepam | Temazepam | 136 | 28 |
| Glipizide | Glipizide | 129 | 38 |
| Pioglitazone Hcl | Pioglitazone Hcl | 127 | 40 |
| Eliquis | Apixaban | 125 | 32 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 119 | 23 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 117 | 94 |
| Fluticasone Propionate | Fluticasone Propionate | 117 | 45 |
| Valsartan | Valsartan | 117 | 32 |
| Meloxicam | Meloxicam | 116 | 34 |
| Diclofenac Sodium | Diclofenac Sodium | 112 | 48 |
| Meclizine Hcl | Meclizine Hcl | 111 | 51 |
| Glipizide Er | Glipizide | 108 | 32 |
| Sildenafil Citrate | Sildenafil Citrate | 108 | 21 |
| Farxiga | Dapagliflozin Propanediol | 106 | 34 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 101 | 29 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 100 | 53 |
| Pravastatin Sodium | Pravastatin Sodium | 100 | 27 |
| Jardiance | Empagliflozin | 97 | 29 |
| Lovastatin | Lovastatin | 91 | 27 |
| Nifedipine Er | Nifedipine | 89 | 23 |
| Cephalexin | Cephalexin | 88 | 77 |
| Clonidine Hcl | Clonidine Hcl | 83 | 28 |
| Quetiapine Fumarate | Quetiapine Fumarate | 83 | 20 |
| Sertraline Hcl | Sertraline Hcl | 82 | 18 |
| Januvia | Sitagliptin Phosphate | 79 | 23 |
| Finasteride | Finasteride | 77 | 24 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 75 | 22 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 74 | 21 |
| Trulicity | Dulaglutide | 73 | 15 |
| Memantine Hcl | Memantine Hcl | 67 | 21 |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 67 | 33 |
| Mirtazapine | Mirtazapine | 64 | 28 |
| Escitalopram Oxalate | Escitalopram Oxalate | 62 | 21 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 62 | 21 |
| Donepezil Hcl | Donepezil Hcl | 59 | 15 |
| Humalog Kwikpen U-100 | Insulin Lispro | 59 | 17 |
| Clobetasol Propionate | Clobetasol Propionate | 56 | 28 |
| Hydrocortisone | Hydrocortisone | 56 | 26 |
| Pregabalin | Pregabalin | 56 | 18 |
| Ezetimibe | Ezetimibe | 55 | 16 |
| Glimepiride | Glimepiride | 54 | 16 |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 52 | 26 |
| Ketoconazole | Ketoconazole | 51 | 25 |
| Baclofen | Baclofen | 48 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 48 | 20 |
| Diazepam | Diazepam | 47 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 46 | 29 |
| Irbesartan | Irbesartan | 46 | 12 |
| Enalapril Maleate | Enalapril Maleate | 45 | 15 |
| Metformin Hcl Er | Metformin Hcl | 45 | 11 |
| Potassium Chloride | Potassium Chloride | 43 | 16 |
| Tresiba Flextouch U-100 | Insulin Degludec | 43 | suppressed |
| Amoxicillin | Amoxicillin | 42 | 34 |
| Breo Ellipta | Fluticasone/Vilanterol | 41 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 41 | 15 |
| Fenofibrate | Fenofibrate | 40 | 13 |
| Ondansetron Hcl | Ondansetron Hcl | 39 | 19 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 38 | 11 |
| Xarelto | Rivaroxaban | 38 | suppressed |
| Dutasteride | Dutasteride | 37 | suppressed |
| Telmisartan | Telmisartan | 37 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 36 | 14 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 36 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 36 | 16 |
| Methylprednisolone | Methylprednisolone | 35 | 32 |
| Valacyclovir | Valacyclovir Hcl | 35 | 19 |
| Clonazepam | Clonazepam | 32 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 32 | 26 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 32 | 27 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 31 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 31 | suppressed |
| Fluocinonide | Fluocinonide | 30 | suppressed |
| Metronidazole | Metronidazole | 30 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 30 | 29 |
| Terazosin Hcl | Terazosin Hcl | 30 | suppressed |
| Spironolactone | Spironolactone | 29 | suppressed |
| Tradjenta | Linagliptin | 29 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 28 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 27 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 27 | 21 |
| Janumet | Sitagliptin Phos/Metformin Hcl | 26 | suppressed |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 25 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 25 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 24 | 20 |
| Doxazosin Mesylate | Doxazosin Mesylate | 24 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 24 | suppressed |
| Neomycin-Polymyxin-Hc | Neomycin/Polymyxin B/Hydrocort | 24 | 16 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 24 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 23 | 11 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 23 | suppressed |
| Moxifloxacin | Moxifloxacin Hcl | 23 | 17 |
| Tizanidine Hcl | Tizanidine Hcl | 23 | 11 |
| Citalopram Hbr | Citalopram Hydrobromide | 22 | suppressed |
| Naproxen | Naproxen | 22 | suppressed |
| Nystatin | Nystatin | 22 | 17 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 22 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 22 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 22 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 22 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 22 | suppressed |
| Colchicine | Colchicine | 21 | suppressed |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 21 | suppressed |
| Fluconazole | Fluconazole | 21 | 18 |
| Lansoprazole | Lansoprazole | 21 | suppressed |
| Nateglinide | Nateglinide | 21 | suppressed |
| Repaglinide | Repaglinide | 21 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 21 | 11 |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 21 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 20 | 18 |
| Novolog Flexpen | Insulin Aspart | 19 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 19 | 11 |
| Carisoprodol | Carisoprodol | 18 | suppressed |
| Celecoxib | Celecoxib | 18 | suppressed |
| Chlorthalidone | Chlorthalidone | 17 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 17 | suppressed |
| Econazole Nitrate | Econazole Nitrate | 17 | suppressed |
| Humalog | Insulin Lispro | 17 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 17 | suppressed |
| Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 17 | suppressed |
| Lactulose | Lactulose | 17 | suppressed |
| Levemir Flexpen | Insulin Detemir | 17 | suppressed |
| Methimazole | Methimazole | 17 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 17 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 17 | suppressed |
| Carbamazepine | Carbamazepine | 16 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 16 | suppressed |
| Mounjaro | Tirzepatide | 16 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 15 | suppressed |
| Glipizide-Metformin | Glipizide/Metformin Hcl | 15 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 15 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 14 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 13 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 13 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 13 | suppressed |
| Mupirocin | Mupirocin | 13 | suppressed |
| Myrbetriq | Mirabegron | 13 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 13 | suppressed |
| Synthroid | Levothyroxine Sodium | 13 | suppressed |
| Acarbose | Acarbose | 12 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 12 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 12 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Risperidone | Risperidone | 12 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 12 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 12 | suppressed |
| Verapamil Er | Verapamil Hcl | 12 | suppressed |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 11 | suppressed |
| Entresto | Sacubitril/Valsartan | 11 | suppressed |
| Febuxostat | Febuxostat | 11 | suppressed |
| Insulin Lispro | Insulin Lispro | 11 | suppressed |
| Lidocaine | Lidocaine | 11 | suppressed |
| Linzess | Linaclotide | 11 | suppressed |
| Procto-Med Hc | Hydrocortisone | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $24.99 · 1 records | GE HEALTHCARE | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error